RxDoctor Payments Data

Guy Lin, MD

Plastic Surgery within the Head & Neck · New York, NYNPI 1346253432

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Sanofi at 25.1% of the total.

$1,518in general payments, 2019–2025

Across 68 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$381
  • GSK$212
  • Kaleo, Inc.$140
  • Optinose US, Inc.$116
  • Stryker$87
  • Hikma Pharmaceuticals USA$84
  • plus $497 from 14 others

What the payments were for

  • Food & beverage$1,518100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,518 in reported general payments places this provider in the 55th percentile of 45 plastic surgery within the head & neck providers in New York.

See all plastic surgery within the head & neck providers in New York

Medicare billing

Part B allowed, 2024
$428,720
Medicare patients
765
Services billed
3,737

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate305$3,537
Ipratropium Bromide100$2,326
Omeprazole96$1,610
Famotidine121$1,538
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,500
Azelastine Hcl55$1,182
Mometasone Furoate19$1,051
Mupirocin77$771
Fluocinolone Acetonide Oil22$764
Prednisone168$520
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav48$443
Cefdinir18$397
Methylprednisolone40$361
Ofloxacin13$341
ValacyclovirValacyclovir Hcl17$317

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →